NCT05428436View on ClinicalTrials.gov

A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 15, 2022

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Healthy
Interventions
DRUG

BI 1015550 ICF

BI 1015550 intended Commercial Formulation (iCF)

DRUG

BI 1015550 TF2

BI 1015550 trial formulation 2 (TF2)

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05428436 - A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food | Biotech Hunter | Biotech Hunter